First Trust ARCA Biotechnology UCITS ETF

Issuer: First Trust

Asset Class: Equity

TER: 60bps

Trading Currency: GBX

Pays Income: False

Listing Date: 29 May 2020

Ticker: FBT

ISIN: IE00BL0L0H60

This fund offers targeted exposure to the dynamic biotechnology sector, comprised of companies at the forefront of medical innovation. It aims to replicate the performance of an index of firms primarily engaged in using biological processes to develop drugs and diagnostic technologies for treating diseases. The investment thesis is rooted in the high-growth potential of this industry, which is fueled by scientific breakthroughs, an aging global population demanding better healthcare solutions, and continuous advancements in areas like genomics and personalized medicine. By investing in this basket of companies, one can gain access to a sector that is integral to the future of healthcare.

A key feature of the underlying index is its equal-weighting methodology. Unlike traditional market-cap-weighted indices where a few large corporations dominate, this approach assigns the same significance to each constituent, regardless of its size. This strategy enhances diversification across the sector, preventing over-concentration in established giants and providing greater exposure to the growth potential of smaller, emerging biotech firms that could be the source of the next major medical breakthrough. This construction allows for a more balanced representation of the industry's landscape, capturing a broader spectrum of innovation.

This thematic investment is positioned to capitalize on long-term secular growth trends in health and science. However, the biotechnology sector is known for its high volatility and inherent risks, including the binary outcomes of clinical trials and stringent regulatory hurdles. Therefore, this product is most suitable for investors with a long-term investment horizon and a higher tolerance for risk, looking to allocate a portion of their portfolio to a high-growth, cutting-edge industry.